Breast Cancer Risk Elevated With Levonorgestrel-Releasing Intrauterine System Use
By Elana Gotkine HealthDay Reporter
FRIDAY, Oct. 18, 2024 -- Women using levonorgestrel-releasing intrauterine systems (LNG-IUS) have an increased risk for breast cancer, according to a study published online Oct. 16 in the Journal of the American Medical Association.
Lina Steinrud Mørch, Ph.D., from the Danish Cancer Institute in Copenhagen, Denmark, and colleagues examined breast cancer risk with continuous use of an LNG-IUS using data from nationwide Danish registers. All first-time initiators of any LNG-IUS aged 15 to 49 years in 2000 to 2019 were identified and matched to nonusers of hormonal contraceptives on the date of initiation (index date). The association between continuous LNG-IUS and breast cancer was examined, adjusting for confounding variables.
The analysis included 78,595 new LNG-IUS users and 78,595 nonusers of hormonal contraceptives. The researchers found that 1,617 participants were diagnosed with breast cancer during a mean follow-up of 6.8 years: 720 LNG-IUS users and 897 nonusers. The hazard ratio for breast cancer was 1.4 for LNG-IUS use versus nonuse. The hazard ratios were 1.3, 1.4, and 1.8 for zero to five, five to 10, and more than 10 to 15 years of use, respectively, compared with the corresponding durations of nonuse, resulting in an excess of 14, 29, and 71 breast cancer diagnoses per 10,000 users (P = 0.15 for trend).
"Given the increase in LNG-IUS use among females at an age with some risk for breast cancer, and its likely long-term use, information about breast cancer risk should accompany discussions about benefits and risks," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
AI Support Improves Breast Cancer Detection Accuracy in Mammography
MONDAY, July 14, 2025 -- Artificial intelligence (AI) support improves radiologists' breast cancer detection accuracy when reading mammograms, according to a study published...
Varying Associations ID'd Between Hormone Therapy, Young-Onset Breast Cancer
THURSDAY, July 10, 2025 -- Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in...
Removing Out-of-Pocket Fee Boosts Rates of Digital Breast Mammography
WEDNESDAY, July 9, 2025 -- Removing a modest out-of-pocket fee significantly improves access to digital breast tomosynthesis (DBT; 3D mammography), particularly among underserved...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.